Get the Stockscreener App
4.36
2.35%
-0.105
Organogenesis Holdings Inc stock is traded at $4.36, with a volume of 841.08K.
It is down -2.35% in the last 24 hours and up +39.30% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.465
Open:
$4.45
24h Volume:
841.08K
Relative Volume:
0.62
Market Cap:
$553.08M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
122.13
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-0.91%
1M Performance:
+39.30%
6M Performance:
+30.54%
1Y Performance:
+43.42%
1-Day Range:
$4.29
$4.48
1-Week Range:
$3.77
$4.53
52-Week Range:
$2.28
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.36 | 558.16M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
150.03 | 70.70B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 46.87B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.59 | 45.41B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.96B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.33 | 13.54B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Organogenesis Holdings Inc. Stock Analysis and ForecastExceptional portfolio growth - Jammu Links News
Lexeo Therapeutics (NASDAQ:LXEO) & Organogenesis (NASDAQ:ORGO) Head to Head Analysis - Defense World
Trade Desk Shares Surge 15% Amid S&P 500 Inclusion - AInvest
What makes Organogenesis Holdings Inc. stock price move sharplyProven Trading Plan - Newser
Why Organogenesis Holdings Inc. stock attracts strong analyst attentionFree Investment Risk Control - Newser
How Organogenesis Holdings Inc. stock performs during market volatilitySteady Income Ideas - Newser
Organogenesis applauds CMS’s proposed skin substitute payment changes By Investing.com - Investing.com India
Organogenesis applauds CMS’s proposed skin substitute payment changes - Investing.com Australia
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation - The Manila Times
Organogenesis stock rating reiterated by Cantor Fitzgerald amid reimbursement changes - Investing.com Canada
CMS Reform Backs Premium Wound Care Products, Organogenesis Leads Market Shift | ORGO Stock News - Stock Titan
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga
After-hours movers: FB Financial, MiMedx Group, Organogenesis, and more By Investing.com - Investing.com Canada
Organogenesis Holdings Inc.(NasdaqCM: ORGO) dropped from Russell 3000E Value Index - MarketScreener
Organogenesis Holdings Inc.(NasdaqCM: ORGO) dropped from Russell 3000 Value Index - MarketScreener
Is Organogenesis Holdings, Inc. overvalued or undervalued? - MarketsMojo
Organogenesis Holdings Leads The Charge With 2 Other Promising Penny Stocks - Yahoo Finance
Assenagon Asset Management S.A. Lowers Stock Holdings in Organogenesis (NASDAQ:ORGO) - Defense World
Organogenesis (NASDAQ:ORGO) Shares Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Merit Financial Group LLC Makes New Investment in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings leases 123,000 s/f at The Davis Cos.’ 100 Technology Way - NEREJ
Analysts Set Expectations for Organogenesis FY2026 Earnings - Defense World
Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario - Seeking Alpha
Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews
Millennium Management LLC Raises Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Ameriprise Financial Inc. Sells 61,072 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Insider Buying: Lori Freedman Acquires Shares in Organogenesis H - GuruFocus
3 Growth Companies With High Insider Ownership Achieving 101% Earnings Growth - simplywall.st
Kalkine: Squarepoint Expands Stake in Organogenesis (NASDAQ:ORGO), a Healthcare Peer to FTSE 100 Companies - Kalkine Media
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Mackenzie Financial Corp - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Squarepoint Ops LLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Cut by Nuveen Asset Management LLC - Defense World
Two Sigma Investments LP Has $1.22 Million Stake in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Increased by Bank of America Corp DE - Defense World
Organogenesis: Build On Weakness For Big ReNu Knee OA Payday (NASDAQ:ORGO) - Seeking Alpha
ProShare Advisors LLC Purchases 6,689 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Signs 123,000 SF Life Sciences Lease in Smithfield, Rhode Island - REBusinessOnline
Northern Trust Corp Raises Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis signs full-building lease for biomanufacturing facility in Smithfield - Providence Business News
Promising Penny Stocks To Watch In May 2025 - Yahoo Finance
Organogenesis Inks Full-Building Lease with Davis in RI - Connect CRE
Price T Rowe Associates Inc. MD Sells 24,540 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Expands Footprint with Full-Building Lease at Davis Biomanufacturing Facility in Smithfield, RI - Boston Real Estate Times
Dimensional Fund Advisors LP Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Barclays PLC Grows Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Wells Fargo & Company MN - Defense World
Organogenesis Holdings First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2025 Earnings Call Transcript - Insider Monkey
CLASS ACTION REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. (ORGO) Shareholders of Securities Fraud Class Action Lawsuit - ACCESS Newswire
Organogenesis (NASDAQ:ORGO) Shares Gap Down After Earnings Miss - Defense World
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
3.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):